United States Biotechnology & Medical Research

Latigo Biotherapeutics Inc (LTGO)

Track

Track

Latigo Biotherapeutics Inc witnessed two significant insider purchases on August 10, 2026. Foresite Capital Management V, LLC and James B. Tananbaum each acquired shares valued at $2.52 million, totaling $5.04 million in buying activity. These acquisitions occurred shortly before the company's September earnings report, amid a 90-day stock price decline of 4.7%.
Ticker: LTGO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
Tananbaum James B. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
281.28
Quantity 76,382 -49.2%
Value US$445,772
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-10 B Purchase
3.5
Foresite Capital Management V, LLC
Large shareholder
89,627 -39.0%
471.30
US$972,291 		89,627 -39.0% 471.30 US$972,291
2026-08-10 2026-08-10 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
76,382 -49.2%
281.28
US$445,772 		76,382 -49.2% 281.28 US$445,772
Explore more

More insider trading research around Latigo Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America